about
Topical treatments for chronic plaque psoriasisTopical treatments for chronic plaque psoriasisDoes the English NHS have a 'Health Benefit Basket'?RELATIVE EFFECTIVENESS IN BREAST CANCER TREATMENT: A HEALTH PRODUCTION APPROACHIntegrating funds for health and social care: an evidence reviewPublishing outcome data: is it an effective approach?Systematic searches for the effectiveness of respite care.Value for money and the Quality and Outcomes Framework in primary care in the UK NHS.Hospital admissions for severe mental illness in England: changes in equity of utilisation at the small area level between 2006 and 2010.Optometrist prescribing of therapeutic agents: findings of the AESOP survey.The influence of primary care quality on hospital admissions for people with dementia in England: a regression analysisDoes the quality and outcomes framework reduce psychiatric admissions in people with serious mental illness? A regression analysis.Paying for the quantity and quality of hospital care: the foundations and evolution of payment policy in England.Influencing prescribing in English primary care: the views of primary care organisations.Risk of Care Home Placement following Acute Hospital Admission: Effects of a Pay-for-Performance Scheme for Dementia.Determinants of hospital length of stay for people with serious mental illness in England and implications for payment systems: a regression analysis.The generalisability of pharmacoeconomic studies: issues and challenges ahead.The effectiveness and cost-effectiveness of respite for caregivers of frail older people.UNDERSTANDING VARIATIONS IN RELATIVE EFFECTIVENESS: A HEALTH PRODUCTION APPROACHFactors affecting the uptake of new medicines in secondary care - a literature review.Navigating uncharted waters? How international experience can inform the funding of mental health care in England.Using QALYs in cancer: a review of the methodological limitations.Prioritizing investment in public health and health equity: what can commissioners do?A review of diagnostic process and postdiagnostic support for people with dementia in rural areas.Topical treatments for chronic plaque psoriasis: an abridged Cochrane systematic review.Erratum to: Variations in Performance of Mental Health Providers in the English NHS: An Analysis of the Relationship Between Readmission Rates and Length-of-Stay.Variations in Performance of Mental Health Providers in the English NHS: An Analysis of the Relationship Between Readmission Rates and Length-of-Stay.Integrated Care: A Pill for All Ills?Sexual precocity in a 4 year old boy.Incentivizing preventive services in primary care: perspectives on Local Enhanced Services.Comparison of anticancer drug coverage decisions in the United States and United Kingdom: does the evidence support the rhetoric?Collaborative palliative care for advanced heart failure: outcomes and costs from the 'Better Together' pilot study.Directors of public health as 'a protected species': qualitative study of the changing role of public health professionals in England following the 2013 reforms.Public funding of new cancer drugs: Is NICE getting nastier?The hospital costs of care for stroke in nine European countries.Private sector treatment centres are treating less complex patients than the NHS.Local authority commissioning of NHS Health Checks: A regression analysis of the first three yearsInvestigating the impact of primary care payments on underdiagnosis in dementia: A difference-in-differences analysisWHY DO PATIENTS HAVING CORONARY ARTERY BYPASS GRAFTS HAVE DIFFERENT COSTS OR LENGTH OF STAY? AN ANALYSIS ACROSS 10 EUROPEAN COUNTRIESAre English treatment centres treating less complex patients?
P50
Q24198258-AFB6D4FC-D193-42AF-B120-026A801F2B99Q24241239-CFC60366-20C2-4A5E-8705-8301C6795178Q25257381-9575F780-ABC9-4EED-B980-168280106340Q28073800-5F766B42-C9E4-409F-8119-824389CD57FDQ28084678-EC3677F1-0077-4B52-8221-E0FBDEA9881FQ33232046-93997E08-B630-452C-8BB0-041AF7138ADBQ33326429-CF94E90B-9DBC-41CE-9B82-DF525ABA6CBAQ33806221-581597E3-71CB-4D49-B540-3AEB434C1001Q34477369-62CDC40C-3667-4EF7-9C3F-C803A83B44EFQ34565414-74938E52-09A0-4960-AD3E-AF0EC67D21B4Q35224708-98419456-B7A6-496F-A1B6-378F91B24A92Q35539399-A829AE86-A588-4B1E-A410-7BD57CAAE7D6Q35745703-BFEE8324-DA02-48F6-9C7D-A405B1ABE994Q35845046-8284126D-16EA-4698-8F20-4006A4BCE735Q36030012-23483BDF-89C1-4BC8-92C4-75825106CFDAQ36110883-54D19F3A-F954-49A9-9251-FC4C840513C1Q36604292-D5A59B98-B136-4D73-817B-8D88E761E173Q36736423-39889D36-1BE6-49E7-A1D6-76C1C953D2F8Q36778700-C545B313-1F91-4209-B9B0-A5C159833828Q37211304-1CA1EB44-72DD-452C-A88C-6DBBD8DBBECEQ37875862-B5E0B523-61E4-4C07-80D5-4684E841D279Q37877688-D50A0CE1-1E5B-4724-8441-C53B8A95315BQ38103106-738D0E9B-3DEA-4169-80D8-E359C0610D84Q38117335-B55948F0-B668-4DAD-AFC5-E768C2918C45Q38152471-E5F627FF-4051-4B5B-B98E-0E191451DF64Q39267150-FC8AAD63-203F-449A-8204-9C1B7DF3071FQ39267155-D99C47AE-6780-47B5-A63C-9379CDBFB7C3Q42339447-995A39E9-800A-4494-A794-8CE7ACAE0E8FQ43062316-A2E2B5DE-5EA4-47CD-A6B1-1C21946C38FAQ43723711-5910B3EA-561F-4A2D-A958-31694DF1333FQ44035617-B8422D19-573E-4D13-A48A-645869BD73C8Q45713521-6DFA3052-7993-438F-9A6A-083C7BB06DF2Q46264834-C13B9A43-F94E-4141-8BD4-57B219847646Q46751713-2D5E1A21-F53A-40E9-8A2B-06E36546BC36Q47721986-59060F57-00BA-4626-864A-8217E4194D1DQ55502179-7AD1AC91-38C3-4A9C-9C0F-29E4A12A0235Q57783181-A4F8ED7D-70CE-42F1-9E89-0DE3F9BD9CD9Q57783190-B2AFFCDB-1BC0-44B1-B078-A4DF4698BDBDQ57783270-BEDEDD8B-89AC-41AA-81E3-C8769F38904EQ57783276-4D0EC9ED-ECDA-493C-B244-89781D9D51C3
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anne R Mason
@nl
Anne R Mason
@sl
Anne R. Mason
@en
Anne R. Mason
@es
type
label
Anne R Mason
@nl
Anne R Mason
@sl
Anne R. Mason
@en
Anne R. Mason
@es
prefLabel
Anne R Mason
@nl
Anne R Mason
@sl
Anne R. Mason
@en
Anne R. Mason
@es
P106
P1153
55660512400
P21
P31
P496
0000-0002-5823-3064